Since CD38 is known to play an important role in the NAD+ metabolism and is believed to critically contribute to elevated adenosine levels in myeloma bone marrow niches (58), inhibition of the CD38 enzymatic activity and thereby disturbing the immunosuppressive microenvironment may be an important mechanism of action of #5-CD38-IgG1. This evidence concerns the gene CD38 and plasma cell myeloma.